Robert Levy, M.D.
Neuro-ophthalmology Physician in Chattanooga, Tennessee.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 128 in Neuro-ophthalmology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Source: CMS Medicare Part D Prescriber Public Use File, 2023
What the federal data shows
Robert Levy, M.D. reported a CMS MIPS final score of 75/100 - below the 83.1 national average - and filed 1,810 Medicare Part D claims in 2023.
- 75/100
- MIPS score · -8 vs avg
- 2K
- Part D claims, 2023
- 75%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Robert Levy, M.D.'s MIPS score vs every scored U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure
75 15th percentile higher than 15% of 477,587 scored providers
Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Robert Levy, M.D. sits
This provider among neuro-ophthalmology physician peers
Across the 49 neuro-ophthalmology physician providers who report both Medicare Part D prescribing and a MIPS quality score, Robert Levy, M.D. writes more Part D claims than 94% of them and scores higher on MIPS quality than 14% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Part D claim volume vs MIPS quality, by specialty percentile
Each dot is one neuro-ophthalmology physician peer from a representative sample of 48; the gold marker is Robert Levy, M.D.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
Robert Levy, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 1 hospital affiliation - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Robert Levy, M.D.?
Below national averagePrimary specialty
Medicare Part D claims
MIPS final score
Specialty distribution in Tennessee
How Neuro-ophthalmology Physician compares to other specialties among Tennessee providers
Neuro-ophthalmology Physician ranks #514 among Tennessee's specialties (0% of in-state providers)
Each bar is a specialty's share of the Tennessee provider total, by primary NUCC taxonomy. The highlighted bar is Neuro-ophthalmology Physician; the long tail of smaller specialties is omitted for legibility.
Medicare quality performance, MIPS
Robert Levy, M.D.'s 2023 MIPS final score plotted against the Neuro-ophthalmology Physician national average
- MIPS Final Score
- 75/100
- vs 83.1 national avg · 2023 performance year
MIPS final score (Neuro-ophthalmology Physician) - 75/100 vs national avg 83.1
Quality benchmarks
- National MIPS avg 2023 reporting year
- Specialty volume Neuro-ophthalmology Physician US NPIs
75/100 MIPS final score - 8.1 pts below the 83.1 national average
Quality, Cost, Promoting Interoperability, and Improvement Activities composite score for the 2023 performance year. Specialty: Neuro-ophthalmology Physician.
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Robert Levy, M.D. appears in the CMS NPPES registry as a Neuro-ophthalmology Physician provider holding M.D. credentials at 5715 CORNELISON RD, Chattanooga, TN, 37411, with a listed phone of (423) 892-3937. NPI 1619397635 was issued on 04/17/2014.
Medicare Part D records for calendar year 2023 show 1,810 prescription claims written by this provider, covering 630 Medicare beneficiaries and totaling roughly $207K in drug spend, split 25% brand-name and 75% generic by claim count, with an opioid prescribing rate of 14.8%. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 75/100 for the 2023 performance year, compared with the national average of 83.1.
Neuro-ophthalmology Physician is a narrow specialty nationwide, with 128 enrolled providers across 34 states and an average of 419 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline.
Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist, always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1619397635 |
|---|---|
| Specialty | Neuro-ophthalmology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 04/17/2014 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm Robert Levy, M.D.'s current license status, disciplinary history, and board certifications with the Tennessee Board of Medical Examiners in Tennessee before relying on this page for a clinical or care decision.
How we sourced this profile
Profile fields combine the CMS NPPES monthly snapshot (provider directory, taxonomy, and address) with calendar-year 2023 Medicare Part D and MIPS public-use files when records are present. NPI 1619397635 is the unique 10-digit identifier CMS uses to link Levy across every Medicare, Medicaid, and HIPAA-covered transaction. Read full methodology →
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
Reporting: Group practice
Hospital and facility affiliations
Facilities where Robert Levy, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Robert Levy, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$559
Largest payer
Amgen Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
25% brand-name claims vs 75% generic, on 1,810 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 2,562
- Total Day Supply
- 57,345
- Brand vs Generic
- 25% brand / 75% generic
- Brand Drug Cost
- $173K
- Generic Drug Cost
- $34K
- Opioid Claims
- 268 (14.8% rate)
- Antibiotic Claims
- 132
Patient Demographics
- Average Patient Age
- 75.4 years
- Avg HCC Risk Score
- 1.23
- Gender Split
- 61% female / 39% male
- Age Distribution
- <65: 41, 65-74: 250, 75-84: 244, 85+: 95
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What Robert Levy, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Latanoprost
Latanoprost
291 claims
- Erythromycin
Erythromycin
272 claims
- Oxycodone-Acetamin…
Oxycodone-Acetaminophen
146 claims
- Tramadol Hcl
Tramadol Hcl
118 claims
- Doxycycline Hyclate 109
Doxycycline Hyclate
109 claims
- Lumigan 90
Lumigan
90 claims
- Brimonidine Tartrate 78
Brimonidine Tartrate
78 claims
- Dorzolamide-Timolol 78
Dorzolamide-Timolol
78 claims
| Drug | Claims |
|---|---|
| Latanoprost | 291 |
| Erythromycin Erythromycin Base | 272 |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 146 |
| Tramadol Hcl | 118 |
| Doxycycline Hyclate | 109 |
| Lumigan Bimatoprost | 90 |
| Brimonidine Tartrate | 78 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 78 |
| Neomycin-Polymyxin-Dexameth Neomycin/Polymyxin B/Dexametha | 73 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 70 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Neuro-ophthalmology Physician Overview
How Robert Levy, M.D. fits within the Neuro-ophthalmology Physician landscape nationally.
Robert Levy, M.D.'s 1,810 claims are above the specialty average of 419.
Before you book an appointment
Use this federal record as your verification checklist, not as a recommendation.
- Confirm the NPI record is current in the official CMS registry, providers update their own NPPES details, and moves can lag. Verify this NPI
- Check the active license and any disciplinary history with the Tennessee medical board, federal registration is not a license check. Credential verification guide
- Weigh a second option: compare this provider with a nearby Neuro-ophthalmology Physician peer on Medicare volume and prescribing patterns. Compare providers
Medicare Part D and MIPS figures describe practice patterns in federal programs only, they are not quality ratings, and PlainDoctor does not rate, rank, or recommend providers.
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Tennessee
Frequently Asked Questions
What is Robert Levy, M.D.'s specialty? ▼
How much does Robert Levy, M.D. prescribe under Medicare Part D? ▼
What is Robert Levy, M.D.'s Medicare quality score? ▼
Where is Robert Levy, M.D. located? ▼
What is Robert Levy, M.D.'s NPI number? ▼
Does Robert Levy, M.D. prescribe more brand-name or generic drugs? ▼
Does Robert Levy, M.D. prescribe opioids? ▼
How many Neuro-ophthalmology Physician providers are there in the US? ▼
What drugs does Robert Levy, M.D. prescribe most often? ▼
Does Robert Levy, M.D. accept Medicare? ▼
How can I verify Robert Levy, M.D.'s credentials? ▼
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.
Published by
PlainDoctor
Independent public-data reference that compiles, verifies, and contextualizes official datasets. We do not accept compensation from entities we cover, and every dataset cites its originating public source.